Evidence map›Paper›PMID 35240199›Full record

ArticleThe Journal of infection2022

Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease.

Denise Utami Putri, Chiou-Feng Lin, Ching-Sheng Hung, Chun-Kai Huang, Tsong-Yih Ou, Chun-Yi Lai, Po-Chun Tseng, Chung-Yi Cheng, Chih-Hsin Lee

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Denise Utami PutriPulmonary Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan.
Chiou-Feng LinDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan; Core Laboratory of Immune Monitoring, Office of Research and Development, Taipei Medical University, Taipei 110301, Taiwan; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan; International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan.
Ching-Sheng HungPh.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan; Department of Laboratory Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan.
Chun-Kai HuangDepartment of Laboratory Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.
Tsong-Yih OuDivision of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Chun-Yi LaiDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan; Core Laboratory of Immune Monitoring, Office of Research and Development, Taipei Medical University, Taipei 110301, Taiwan.
Po-Chun TsengDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan; Core Laboratory of Immune Monitoring, Office of Research and Development, Taipei Medical University, Taipei 110301, Taiwan.
Chung-Yi ChengTaipei Medical University Research Center of Urology and Kidney, Taipei 110301, Taiwan; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan. Electronic address: 94426@w.tmu.edu.tw.
Chih-Hsin LeePulmonary Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116081, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan. Electronic address: chleetw@tmu.edu.tw.
Taipei Medical University Hospital · TWTaipei Medical University · TWWan Fang Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney Failure, ChronicNatural Killer T-CellsChAdOx1 nCoV-19COVID-19 VaccinesHumansSARS-CoV-2ChAdOx1 nCoV-19COVID-19 VaccinesChAdOx nCoV-19, vaccine, end-stage renal disease, immunitySARS-CoV-2

Identifiers

PMID35240199
PMCPMC8883673
OpenAlexW4214637337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.